Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 41

Trial Status

Other4

Role Distribution

Principal Investigator1
Other Roles3
PI Rate25%

Activity Timeline

Clinical Trials (4)

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
Chimeric Antigen Receptor T-cell TherapyHematological Malignancies
StudychairStart date: 2023-09-03
NCT05634915Phase 4Unknown
Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation
Acute LeukemiaHematopoietic Stem Cell Transplantation
StudychairStart date: 2022-12-20
NCT06021210Phase 2Unknown
Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS
CMV InfectionHematopoietic Stem Cell Transplantation
StudychairStart date: 2022-07-07
NCT03275493Phase 1/2Unknown
CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaCD19 PositiveRefractory+1 more
PrincipalinvestigatorStart date: 2017-07-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematopoietic Stem Cell TransplantationHematologic NeoplasmsAcute Leukemia+2 more
Similarity Score17%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaRefractory
Similarity Score7%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score7%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Acute LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score7%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score7%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score7%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score7%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score3%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

CMV Infection
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06041815StudyChair

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Chimeric Antigen Receptor T-cell TherapyHematological Malignancies
Unknown
NCT05634915Phase 4StudyChair

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Acute LeukemiaHematopoietic Stem Cell Transplantation
Unknown
NCT06021210Phase 2StudyChair

Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS

CMV InfectionHematopoietic Stem Cell Transplantation
Unknown
NCT03275493Phase 1/2PrincipalInvestigator

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Acute Lymphoblastic LeukemiaCD19 PositiveRefractory+1 more
Unknown

All 4 trials loaded